Navigation Links
Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center

FREDERICK, Md., Aug. 25 /PRNewswire/ -- The recent ruling by federal judge Royce C. Lamberth halting embryonic stem cell research may present a hurdle for some disease research but not necessarily for arthritis.  A key note presentation, entitled "Guided Mesenchymal Stem Cell Layering Technique for Treatment of Osteoarthritis of the Knee" will be made on November 9, 2010 at the annual meeting of the American College of Rheumatology in Atlanta.

Osteoarthritis (OA) is a disease associated with the loss of cartilage, the gristle that caps the ends of long bones and which provides cushioning and shock absorption.  When cartilage wears away, the end result is reduced joint function, and possibly, disability.

According to lead author Dr. Nathan Wei, "Osteoarthritis affects more than 20 million Americans, but our treatment options have been limited to symptom relief... No therapies solve the problem of cartilage loss."

He goes on to say, "Many people aren't aware that there are many different types of stem cells.  Embryonic cells are only one type.  Adult stem cells are readily accessible from bone marrow. Our study shows that adult stem cells may hold the key to successful cartilage regeneration. "

He adds, "We used a 'cocktail' mixture of adult stem cells, platelet rich plasma, better known as PRP, and fat.  The PRP stimulates stem cell growth and the fat provides a framework and bulk for the stem cells to hold onto."

In the study, 22 patients underwent stem cell treatment for osteoarthritis of the knee.  Data was available for 20 patients, ranging in age from 36 to 84 years.  There were 15 men and 5 women.  

Clinical assessments as well as ultrasound measurement of cartilage thickness were performed.

There were three treatment failures, defined as patients who did not improve above baseline.

Data was available at the time of abstract submission for 11 patients at 6 months and 8 patients at one year.  Significant improvements in clinical measures and cartilage thickness were demonstrated.

Dr. Wei cautions, "This was an uncontrolled study.  And, obviously further refinements of technique as well as many unanswered questions remain.  Further studies are warranted."

Dr. Wei is a board-certified rheumatologist and a regenerative medicine specialist who practices in Frederick, Maryland.

SOURCE Arthritis Treatment Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Impact of Very Small Embryonic-Like Stem Cells in Regenerative Medicine is Highlighted by Five Posters and Two Oral Presentations at the 2009 American Society of Hematology Annual Meeting
2. Roundtable Calls Presidents Embryonic Stem Cell Decision: Bankrupt
3. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
4. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
5. New Studies End Debate on Embryonic Stem Cell Research
6. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
7. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
8. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
9. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
10. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
11. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... ScanWise Implant, the industry,s first MRI guided user interface ... scanning of patients with MR Conditional implants, such as ... the 2015 Radiological Society of North America Annual ... exams and supports diagnostic confidence of this growing patient ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... PUNE, India , November 30, 2015 ... new market research report "Dental Lasers Market by Product (Soft ... Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global ... USD 224.7 Million by 2020, at a CAGR of 5.2% ... , Browse 140 market data Tables and 62 Figures spread ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... December 01, 2015 , ... ... Colon as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting 850,000 members ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... networking organization exclusively for professional women, boasting 850,000 members and over 200 operating ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Until now, ... criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One of these ... Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, 25 - ...
(Date:11/30/2015)... ... 2015 , ... Stress, anxiety, illness, infection or even a need for eyeglasses ... Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, ... tumors. , “Bad headaches that don’t go away, that don’t have any ...
Breaking Medicine News(10 mins):